Store lyophilized MT-2 at -20C protected from light
It will eventually improve adherence among patients who struggle with injection administration
It may also be considered in supportive care conversations related to cataracts, glaucoma, aging, alcoholism, heart disease, liver disease, lung disease, Alzheimer's disease, Parkinson's disease, osteoarthritis, immune system concerns, and other chronic wellness concerns
If you would like to learn more about our Wellness Program and are ready to take the first step in your weight loss journey, contact us today
Anita Clayton has been a principal investigator in the clinical development of bremelanotide (PT-141) for female sexual dysfunction, leading multiple Phase 2 and Phase 3 trials that established the efficacy and safety profile supporting FDA approval